Shamburg News · 8-K filed Nov 9, 2026, 7:20 AM EST

Tonix Pharmaceuticals Reports Operating Results for Quarter Ended September 30, 2026

TNXP · Tonix Pharmaceuticals Holding Corp.

  • Earnings
  • Materiality: medium

On November 9, 2026, Tonix Pharmaceuticals Holding Corp. announced its operating results for the quarter ended September 30, 2026. The results are described in a press release filed as Exhibit 99.01 to the report, which is incorporated by reference. The filing itself does not state specific revenue, net income, or per-share figures in the text provided.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001493152-26-050621.

Written from the filing by Shamburg Markets. Figures are as reported by the company.